BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:36 PM
 | 
Feb 21, 2008
 |  BC Extra  |  Company News

Astellas extends deal with MorphoSys

Astellas (Tokyo:4503) exercised an option to extend until March 2012 a license to MorphoSys' HuCAL GOLD antibody library for internal discovery programs. The four-year extension of the 2007 license includes an option...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >